| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zai Lab Ltd | Head of Global Dev., Oncology | Restricted Share Units | 73,000 | $1,906,906 | $26.12 | 25 Jun 2022 | Direct |
| Zai Lab Ltd | Head of Global Dev., Oncology | Ordinary Shares | 27,925 | $1,400,997 | $50.17 | 01 Dec 2021 | Direct |
| Zai Lab Ltd | Head of Global Dev., Oncology | American Depositary Shares | 28,985 | $757,146 | $26.12 | 01 Apr 2022 | Direct |
| ALX ONCOLOGY HOLDINGS INC | Director | Employee Stock Option (right to buy) | 125,000 | 11 Apr 2025 | Direct | ||
| Zai Lab Ltd | Head of Global Dev., Oncology | Stock Options (Right to Buy) | 87,699 | 01 Apr 2022 | Direct | ||
| ALX ONCOLOGY HOLDINGS INC | Director | Stock option (right to buy) | 10,100 | 20 Jan 2026 | Direct | ||
| Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | 23 Jul 2025 | Direct | ||
| Mirati Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $59.02 | 23 Jan 2024 | Direct | |
| Mirati Therapeutics, Inc. | Chief Medical Officer | Option to Purchase Common Stock | 0 | 23 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HOLDINGS INC | 20 Jan 2026 | 1 | $0 | 4 | Director | 21 Jan 2026, 16:30 |
| ELEV | Elevation Oncology, Inc. | 23 Jul 2025 | 3 | $0 | 4 | Director | 24 Jul 2025, 16:40 |
| ELEV | Elevation Oncology, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:30 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 11 Apr 2025 | 1 | $0 | 4 | Chief Medical Officer | 15 Apr 2025, 16:19 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 21 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 23 Jan 2025, 18:11 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 18 Nov 2024 | 1 | $0 | 4 | Chief Medical Officer | 19 Nov 2024, 16:05 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 05 Aug 2024 | 1 | $0 | 4 | Director | 07 Aug 2024, 17:23 |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 05 Aug 2024 | 0 | $0 | 3 | Director | 07 Aug 2024, 17:22 |
| ELEV | Elevation Oncology, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:30 |
| ELEV | Elevation Oncology, Inc. | 29 Feb 2024 | 1 | $0 | 4 | Director | 04 Mar 2024, 16:40 |
| ELEV | Elevation Oncology, Inc. | 29 Feb 2024 | 0 | $0 | 3 | Director | 04 Mar 2024, 16:21 |
| /report/000114036124003530-sandler-alan-b-2024-01-23 | Mirati Therapeutics, Inc. | 23 Jan 2024 | 4 | $0 | 4 | Chief Medical Officer | 23 Jan 2024, 20:37 |
| /report/000162828024000282-sandler-alan-b-2023-12-29 | Mirati Therapeutics, Inc. | 29 Dec 2023 | 1 | +$999,984 | 4 | Chief Medical Officer | 03 Jan 2024, 18:01 |
| /report/000162828023028871-sandler-alan-b-2023-08-09 | Mirati Therapeutics, Inc. | 09 Aug 2023 | 1 | +$824,989 | 4 | Chief Medical Officer | 10 Aug 2023, 16:19 |
| /report/000121465922013305-sandler-alan-b-2022-11-07 | Mirati Therapeutics, Inc. | 07 Nov 2022 | 2 | $0 | 4 | Chief Medical Officer | 08 Nov 2022, 17:00 |
| /report/000121465922013304-sandler-alan-b-2022-11-07 | Mirati Therapeutics, Inc. | 07 Nov 2022 | 0 | $0 | 3 | Chief Medical Officer | 08 Nov 2022, 17:00 |
| ZLAB | Zai Lab Ltd | 25 Jun 2022 | 1 | $0 | 4 | Head of Global Dev., Oncology | 27 Jun 2022, 21:44 |
| ZLAB | Zai Lab Ltd | 01 Apr 2022 | 4 | $0 | 4 | Head of Global Dev., Oncology | 05 Apr 2022, 16:05 |
| ZLAB | Zai Lab Ltd | 01 Dec 2021 | 1 | -$147,802 | 4 | Head of Global Dev., Oncology | 03 Dec 2021, 17:29 |